Trial Profile
Efficacy of Etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2018
Price :
$35
*
At a glance
- Drugs Etelcalcetide (Primary)
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- 29 Jul 2018 New trial record